Hematopoiesis News Volume 14.25 | Jun 27 2023

    0
    16







    2023-06-27 | HN 14.25


    Hematopoiesis News by STEMCELL Technologies
    Vol. 14.25 – 27 June, 2023
    TOP STORY

    Inhibition of a New AXL Isoform (AXL3) Induces Apoptosis of Mantle Cell Lymphoma Cells

    Scientists reported the identification and expression of a new isoform splice variant of the tyrosine kinase receptor AXL in mantle cell lymphoma (MCL) cells. This new AXL isoform, AXL3, lacked the ligand-binding domain of the commonly described AXL splice variants and was constitutively activated in MCL cells.
    [Blood]

    Abstract
    Enjoy your weekend. Your cells will too. Reduce medium acidosis with mTeSRâ„¢ Plus.
    PUBLICATIONSRanked by the impact factor of the journal

    Loss of miR-144/451 Alleviates β-Thalassemia by Stimulating ULK1-Mediated Autophagy of Free α-Globin

    Investigators showed that disruption of the bi-cistronic microRNA locus miR-144/451 alleviated β-thalassemia by reducing mTORC1 activity and stimulating ULK1-mediated autophagy of free α-globin through two mechanisms.
    [Blood]

    Abstract

    Sulfated Polysaccharide Regulates the Homing of HSPCs in a BMP-2-Triggered In Vivo Osteo-Organoid

    Researchers demonstrated that targeting the homing signaling of hematopoietic stem/progenitor cells (HSPCs) elevated the proportions and biological functions of HSPCs in the in vivo osteo-organoid.
    [Advanced Science]

    Full Article

    Inhibition of GPIb-α-Mediated Apoptosis Signaling Enables Cold Storage of Platelets

    Scientists investigated the impact of apoptosis inhibition on the hemostatic functions and survival of cold-stored platelets (CSPs). They found that blocking the transduction of the apoptotic signal induced by glycoprotein Ib (GPIb)-alpha clustering or the activation of caspase 9 did not impair CSPs functionality.
    [Haematologica]

    Abstract

    Interleukin-27 Potentiates CD8+ T-Cell-Mediated Anti-Tumor Immunity in Chronic Lymphocytic Leukemia

    Researchers utilized the Eμ-TCL1 and EBI3 knock-out mouse models as well as clinical samples from patients to investigate the role of IL-27 in chronic lymphocytic leukemia.
    [Haematologica]

    Abstract

    A Novel Computational Method Enables RNA Editome Profiling during Human Hematopoiesis from scRNA-Seq Data

    Scientists developed a computational method to systematically identify RNA editing sites of cell types from scRNA-seq data. It was applied to scRNA-seq data of human hematopoietic stem/progenitor cells with an annotated lineage differentiation relationship and studied for the impacts of RNA editing on hematopoiesis.
    [Scientific Reports]

    Full Article

    Risks Factors and Outcomes for Isolated Catheter-Related Deep Venous Thrombosis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

    Researchers conducted a retrospective cohort study for patients undergoing allogeneic hematopoietic stem cell transplantation from 2006 to 2019. Catheter-related deep venous thrombosis and pulmonary embolism/lower-extremity deep venous thrombosis outcomes were screened.
    [Thrombosis Research]

    Abstract

    Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation for Adolescent and Young Adults with Acute Myeloid Leukemia

    Scientists identified the efficacy of haploidentical-related donor hematopoietic stem cell transplantation in adolescents and young adults with AML in a large cohort.
    [British Journal Of Haematology]

    Abstract

    Determinants of Frontline Tyrosine Kinase Inhibitor Choice for Patients with Chronic-Phase Chronic Myeloid Leukemia: A Study from the Registro Italiano LMC and Campus CML

    A total of 1967 patients with chronic-phase chronic myeloid leukemia diagnosed between 2012 and 2019 at 36 centers throughout Italy were retrospectively evaluated; 1089 patients received imatinib and 878 patients received a second-generation tyrosine kinase inhibitor.
    [Cancer]

    Full Article
    Dr. Kristina McBurney and Leanna Bedell discuss how you can use social media to advance your scientific career. Watch now.
    REVIEWS

    Relapsed Acute Lymphoblastic Leukemia

    Over the last decade, new therapeutic options and strategies have been developed for relapsed acute lymphoblastic leukemia (ALL) including immunotherapies and cellular therapies. It is imperative to understand how and when to use these newer approaches in relapsed ALL.
    [Indian Journal Of Pediatrics]

    Full Article
    INDUSTRY AND POLICY NEWS

    Central Clinical School Professors Recognised in 2023 King’s Birthday Honours

    Professor Harshal Nandurkar was awarded the member of the General Division as part of this year’s King’s Birthday Honours. He was recognized for his significant service to medicine, particularly as a hematologist.
    [Monash University]

    Press Release
    FEATURED EVENT

    Amygdala Function in Emotion, Cognition, and Disease

    July 9 – 14, 2023
    Barcelona, Spain

    > See All Events

    JOB OPPORTUNITIES

    Professor – Hematology & Oncology

    St. Jude Children’s Research Hospital – Memphis, Tennessee, United States

    Postdoctoral Position – Cancer Metabolism, Epigenetics & Hematopoiesis Research

    University of Texas Health Science Center San Antonio – San Antonio, Texas, United States

    Associate Professor – Pediatric Blood and Marrow Transplantation

    Fred Hutchinson Cancer Center – Seattle, Washington, United States

    Postdoctoral Research Associate – Hematopoietic Stem and Progenitor cells

    University Hospital RWTH Aachen – Aachen, Germany

    Technician/Senior Technician – Stem Cell Biology & Functional Genomics

    Human Technopole – Milan, Italy

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hematopoiesis News Twitter